MAQUET Critical Care, Solna, Sweden, today announced the launch of Neurally Adjusted Ventilatory Assist (NAVA) for noninvasive ventilation (NIV) in neonatal patients at the Third Congress of the European Academy of Paediatric Societies in Copenhagen, Denmark.

In conventional NIV, patient-ventilator asynchrony is common. Studies suggest that leaks may play a major role in generating patient-ventilator asynchrony and discomfort.

NAVA provides synchronized assist, while breath triggering and cycle-off are not affected by leakage. According to the company, every patient effort is assessed and responded to equally effectively regardless of patient interface used, resulting in reduced work of breathing and increased patient comfort.

NAVA has been associated with improved patient-ventilator synchrony and lower peak airway pressure in neonatal and pediatric patient populations when compared with pressure support ventilation, according to Jens Viebke, president of MAQUET Critical Care.

Source: MAQUET Critical Care